New Evidence FDA, CDC Hid Early Data on Myocarditis Spurs Questions of ‘Criminal Coverup’ – Children’s Health Defense 5/23/23


New evidence suggesting public health officials knew early in 2021 that COVID-19 vaccines posed a heightened risk of myocarditis in young men — but withheld that information from the public — raises questions about whether federal health agencies violated any laws.

According to Dr. Meryl Nass, the U.S. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) knew about the myocarditis safety signal in February 2021, but “hid it until they got the vaccine authorized for 12-15-year-olds in May 2021,” and then “kept pushing” the vaccine on the highest-risk groups.”

Nass said the new evidence suggests the CDC and FDA may have violated the Public Readiness and Emergency Preparedness Act (PREP Act) when they withheld knowledge about myocarditis safety signals from the public and from fact sheets included with the COVID-19 vaccines.

The new evidence includes warnings the FDA received from multiple sources, including the Israeli Ministry of Health at least as early as February 2021.

Nass, an internist, biological warfare epidemiologist and member of the Children’s Health Defense (CHD) scientific advisory committee, this week discussed the new revelations in two Substack posts and on CHD.TV.

In an interview with The Defender, Nass said the newly discovered revelations “provide clear evidence that the agencies knew of the connection and kept it under wraps, and did not inform their advisory committees till after the vaccine was approved for the teens.”

Kim Mack Rosenberg, acting outside general counsel for CHD, told The Defender:

“As more and more information becomes publicly available, it becomes ever clearer that claims that EUA [Emergency Use Authorization] vaccines were safe and effective ring hollow, at best.

“While the PREP Act purposefully creates challenges to suing the parties responsible for this debacle, Children’s Health Defense continues to pursue possible ways to seek justice for those injured and betrayed.”

Brian Hooker, Ph.D., P.E., chief scientific officer for CHD and co-author of the October 2022 study that first revealed the CDC’s and FDA’s knowledge of the myocarditis safety signal in February 2021, said the new revelations suggest the actions of the two agencies were “criminal.”

Hooker told The Defender:

“The paper I published with Dr. Karl Jablonowski makes it clear that the CDC knew about the myocarditis signal at least as early as Feb. 19, 2021 — when the signal became significant on VAERS [Vaccine Adverse Event Reporting System].  This is when the vaccination rate in the U.S. was about 8%.

“Despite mounting evidence from multiple sources that this was a huge problem, the CDC chose to hide this signal until they finally, quietly posted a new website suggesting there might be a myocarditis signal on May 27, 2021. At that point, the vaccination rate had risen to about 50%.

“CDC let 42% of the U.S. population get vaccinated, knowing full well that mRNA vaccines were causing myocarditis, which is criminal.”

Cardiologist Dr. Peter McCullough, an outspoken critic of COVID-19 vaccines, characterized the delayed acknowledgment of myocarditis safety signals by the CDC and FDA as “astounding” and referenced the growing numbers of athletes affected by the condition after their vaccination.

McCullough told The Defender:

“What is even more astounding is that professional sports leagues — for example, the National Football League — mandated (starting August 2021) the heart-damaging COVID-19 vaccines after the CDC/FDA warning in June 2021.

“The cardiology position papers before COVID-19 clearly warned that exercise during active myocarditis is strictly prohibited because it can trigger a cardiac arrest. Once the vaccines were mandated, none of the teams took adequate safety measures for the players.”

By April 23, 2021, VAERS data showed the discerned level of myocarditis in young men following COVID-19 vaccination had increased to an extreme statistical level, indicating a very low likelihood that the connection between the level of myocarditis cases in this population and COVID-19 vaccination was attributable to chance.

Despite this safety signal, the FDA on May 10, 2021, expanded the EUA of the Pfizer-BioNTech COVID-19 vaccine for use in people as young as 12 years old, and the CDC’s Advisory Committee on Immunization Practices (ACIP) voted to recommend that all persons 12 or older get the vaccine….

Read More…